妊娠20周前血压正常的慢性高血压女性的围产期结局
本回顾性队列研究比较了妊娠20周前血压正常的慢性高血压女性(按是否使用降压药分层)与无慢性高血压女性的围产期结局。主要结局为围产期复合不良结局,包括死产、新生儿死亡、出生时呼吸支持、脐动脉血pH小于7、5分钟Apgar评分3分或以下及惊厥。结果显示,两高血压组的围产期复合结局发生率均高于对照组,调整OR分别为2.9和5.0。
要点
- 妊娠20周前血压正常的慢性高血压女性,围产期复合不良结局风险仍高于无慢性高血压者。
- 未用降压药组复合结局发生率为9.9%,用降压药组为14.6%,对照组为2.9%。
- 未用降压药组早产(<37周和<34周)、小于胎龄儿和子痫前期的风险较无慢性高血压女性无显著升高。
核心结论
- 尽管妊娠20周前未用药时血压正常,慢性高血压女性相比无慢性高血压女性围产期不良结局风险仍增加。
研究设计与样本
- 回顾性队列研究,纳入2000年至2014年所有单胎且有慢性高血压病史的女性。
- 排除妊娠20周前血压大于140/90 mm Hg、胎儿畸形、除高血压外的主要内科疾病及糖尿病。
- 同期随机选取无慢性高血压诊断且符合相同排除标准的女性作为对照组。
- 比较三组:无慢性高血压组、慢性高血压未用降压药且20周前血压<140/90 mm Hg组、慢性高血压用降压药且20周前血压<140/90 mm Hg组。
- 主要结局为围产期复合结局:死产、新生儿死亡、出生时呼吸支持、脐动脉血pH<7、5分钟Apgar评分≤3及惊厥。
主要发现
- 共830例慢性高血压且20周前血压<140/90 mm Hg女性,其中212例(26%)未用降压药,618例(74%)用降压药;对照组476例无慢性高血压。
- 高血压组女性相比无高血压组更可能年龄较大、有基线肾脏疾病和糖尿病。
- 围产期复合结局发生率:未用降压药组9.9%,用降压药组14.6%,对照组2.9%。
- 未用降压药组 vs 无慢性高血压组调整OR 2.9(95% CI 1.21-6.85);用降压药组 vs 无慢性高血压组调整OR 5.0(95% CI 2.38-10.54)。
- 未用降压药组相比无慢性高血压组,早产(<37周和<34周)、小于胎龄儿和子痫前期风险无显著增加。
关键数值与推荐
- 围产期复合结局包括死产、新生儿死亡、出生时呼吸支持、脐动脉血pH<7、5分钟Apgar评分≤3及惊厥。
- 高血压组定义为有慢性高血压病史且妊娠20周前血压<140/90 mm Hg,按是否使用降压药分层。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the perinatal outcomes of normotensive women with those of women with a history of chronic hypertension with normal blood pressures before 20 weeks of gestation, stratifying the latter by whether they were receiving antihypertensive medication. METHODS: We conducted a retrospective cohort study of all singletons with a history of chronic hypertension from 2000 to 2014. Exclusions were blood pressure greater than 140/90 mm Hg before 20 weeks of gestation, fetal anomalies, major medical problems other than hypertension, and diabetes. For the same time period, a randomly selected group without a diagnosis of chronic hypertension was chosen using the same exclusion criteria. Outcomes were compared among women without chronic hypertension, women with chronic hypertension on no antihypertensive medication but with blood pressures less than 140/90 mm Hg before 20 weeks of gestation, and women with chronic hypertension on antihypertensive medication with blood pressures less than 140/90 mm Hg before 20 weeks of gestation. The primary outcome was a perinatal composite of stillbirth, neonatal death, respiratory support at birth, arterial cord pH less than 7, 5-minute Apgar score 3 or less, and seizures. Secondary outcomes assessed were preterm birth before 37 and 34 weeks of gestation, small for gestational age, and preeclampsia. RESULTS: Of 830 women with chronic hypertension and blood pressures less than 140/90 mm Hg before 20 weeks of gestation, 212 (26%) were not taking antihypertensive medication and 618 (74%) were. These groups were compared with 476 women without chronic hypertension. Women with hypertension were more likely to be older and have baseline renal disease and diabetes compared with women in the no hypertension group. The perinatal composite was more common in both hypertensive groups: no antihypertensive medication (9.9%) and antihypertensive medication (14.6%) compared with women in the control group (2.9%) (adjusted odds ratio [OR] 2.9, 95% CI 1.21-6.85 no antihypertensive medications compared with no chronic hypertension; adjusted OR 5.0, 95% CI 2.38-10.54 antihypertensive medications vs no chronic hypertension). The risk of early preterm birth, small for gestational age, and preeclampsia was not significantly increased in women with chronic hypertension and no antihypertensive medications compared with women without chronic hypertension. CONCLUSION: Despite normal baseline blood pressures without medications before 20 weeks of gestation, women with chronic hypertension are at an increased risk of adverse perinatal outcomes compared with women without.
引用
- Youngstrom M, Tita A, Grant J, et al. Perinatal Outcomes in Women With a History of Chronic Hypertension but Normal Blood Pressures Before 20 Weeks of Gestation. Obstet Gynecol. 2018. PMID: 29630010. doi:10.1097/AOG.0000000000002574
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。